INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2005

Glucosamine improved osteoarthritis pain and function in pooled RCTs, though benefits were not seen in studies with adequate allocation concealment.

A systematic review and meta-analysis of 20 RCTs evaluated the efficacy and safety of glucosamine in 2,570 osteoarthritis patients. Overall, glucosamine outperformed placebo with a 28% improvement in pain (SMD -0.61, 95% CI -0.95 to -0.28) and a 21% improvement in Lequesne function (SMD -0.51, 95% CI -0.96 to -0.05), but WOMAC pain, function, and stiffness did not reach statistical significance. Analysis restricted to eight studies with adequate allocation concealment failed to show benefit for pain or WOMAC function. Benefits were observed in trials using the Rotta preparation, whereas non-Rotta preparations did not achieve statistically significant improvements in pain or WOMAC function. Glucosamine was as safe as placebo regarding adverse reactions (RR 0.97, 95% CI 0.88 to 1.08).

Study type
Systematic review and meta-analysis of RCTs
Who was studied
2,570 patients with osteoarthritis across 20 randomized controlled trials
What was measured
Pain, functional impairment (Lequesne and WOMAC indices), stiffness, radiological progression, and adverse reactions

THE PAPER

Glucosamine therapy for treating osteoarthritis.

Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, Hochberg MC, Wells G. Cochrane Database Syst Rev, 2005.

PubMed 15846645 ↗DOI 10.1002/14651858.cd003831 ↗

Bones & musclesOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.